Which Change Will Most Likely Result In A Frameshift Mutation?

Mutation that shifts codon alignment

Different types of indel mutation. Panel C is simply a deletion and not a frameshift mutation.

A frameshift mutation (likewise called a framing fault or a reading frame shift) is a genetic mutation caused by indels (insertions or deletions) of a number of nucleotides in a Deoxyribonucleic acid sequence that is not divisible past 3. Due to the triplet nature of gene expression by codons, the insertion or deletion can change the reading frame (the group of the codons), resulting in a completely different translation from the original. The earlier in the sequence the deletion or insertion occurs, the more than altered the protein.^[1] A frameshift mutation is not the same as a single-nucleotide polymorphism in which a nucleotide is replaced, rather than inserted or deleted. A frameshift mutation will in general cause the reading of the codons after the mutation to code for different amino acids. The frameshift mutation will as well modify the kickoff finish codon ("UAA", "UGA" or "UAG") encountered in the sequence. The polypeptide existence created could exist abnormally short or abnormally long, and will most likely not be functional.^[2]

Frameshift mutations are apparent in severe genetic diseases such as Tay–Sachs disease; they increase susceptibility to certain cancers and classes of familial hypercholesterolaemia; in 1997,^[3] a frameshift mutation was linked to resistance to infection by the HIV retrovirus. Frameshift mutations have been proposed as a source of biological novelty, every bit with the alleged creation of nylonase, however, this interpretation is controversial. A report past Negoro et al (2006)^[4] found that a frameshift mutation was unlikely to have been the cause and that rather a 2 amino acid exchange in the active site of an ancestral esterase resulted in nylonase.

Background [edit]

The information contained in DNA determines protein function in the cells of all organisms. Transcription and translation permit this information to exist communicated into making proteins. However, an error in reading this communication tin can cause poly peptide function to exist wrong and somewhen cause disease even equally the prison cell incorporates a variety of corrective measures.

Cardinal dogma [edit]

In 1956 Francis Crick described the flow of genetic information from Deoxyribonucleic acid to a specific amino acid organisation for making a protein equally the fundamental dogma.^[i] For a cell to properly office, proteins are required to be produced accurately for structural and for catalytic activities. An incorrectly made protein tin have detrimental effects on jail cell viability and in almost cases cause the higher organism to become unhealthy past abnormal cellular functions. To ensure that the genome successfully passes the information on, proofreading mechanisms such as exonucleases and mismatch repair systems are incorporated in DNA replication .^[1]

Transcription and translation [edit]

Subsequently Dna replication, the reading of a selected department of genetic information is accomplished by transcription.^[1] Nucleotides containing the genetic data are now on a single strand messenger template called mRNA. The mRNA is incorporated with a subunit of the ribosome and interacts with an rRNA. The genetic information carried in the codons of the mRNA are now read (decoded) by anticodons of the tRNA. Equally each codon (triplet) is read, amino acids are being joined together until a stop codon (UAG, UGA or UAA) is reached. At this point the polypeptide (protein) has been synthesised and is released.^[1] For every thou amino acrid incorporated into the protein, no more than than one is wrong. This fidelity of codon recognition, maintaining the importance of the proper reading frame, is accomplished by proper base pairing at the ribosome A site, GTP hydrolysis activity of EF-Tu a form of kinetic stability, and a proofreading mechanism every bit EF-Tu is released.^[1]

Frameshifting may as well occur during prophase translation, producing different proteins from overlapping open reading frames, such as the gag-pol-env retroviral proteins. This is fairly common in viruses and also occurs in bacteria and yeast (Farabaugh, 1996). Contrary transcriptase, as opposed to RNA Polymerase II, is thought to exist a stronger cause of the occurrence of frameshift mutations. In experiments merely 3–thirteen% of all frameshift mutations occurred because of RNA Polymerase 2. In prokaryotes the error charge per unit inducing frameshift mutations is just somewhere in the range of .0001 and .00001.^[5]

There are several biological processes that help to forestall frameshift mutations. Reverse mutations occur which modify the mutated sequence back to the original wild blazon sequence. Another possibility for mutation correction is the apply of a suppressor mutation. This offsets the effect of the original mutation by creating a secondary mutation, shifting the sequence to permit for the correct amino acids to be read. Guide RNA can likewise exist used to insert or delete Uridine into the mRNA after transcription, this allows for the correct reading frame.^[1]

Codon-triplet importance [edit]

The iii letter of the alphabet code, the codon

A codon is a prepare of three nucleotides, a triplet that code for a certain amino acid. The offset codon establishes the reading frame, whereby a new codon begins. A protein'due south amino acid backbone sequence is defined by contiguous triplets.^[6] Codons are key to translation of genetic information for the synthesis of proteins. The reading frame is ready when translating the mRNA begins and is maintained as it reads one triplet to the next. The reading of the genetic code is subject to iii rules the monitor codons in mRNA. First, codons are read in a v' to 3' direction. Second, codons are nonoverlapping and the bulletin has no gaps. The last rule, as stated higher up, that the bulletin is translated in a fixed reading frame.^[1]

Example of different types of point mutations

Mechanism [edit]

Frameshift mutations can occur randomly or be caused past an external stimulus. The detection of frameshift mutations can occur via several different methods. Frameshifts are just 1 type of mutation that tin can pb to incomplete or wrong proteins, but they account for a significant percentage of errors in DNA.

Genetic or environmental [edit]

This is a genetic mutation at the level of nucleotide bases. Why and how frameshift mutations occur are continually being sought later on. An environmental study, specifically the production of UV-induced frameshift mutations by Deoxyribonucleic acid polymerases deficient in 3′ → 5′ exonuclease activeness was done. The normal sequence 5′ GTC GTT TTA CAA iii′ was changed to GTC GTT T TTA CAA (MIDT) of GTC GTT C TTA CAA (MIDC) to written report frameshifts. E. coli pol I Kf and T7 DNA polymerase mutant enzymes devoid of three′ → v′ exonuclease action produce UV-induced revertants at higher frequency than did their exonuclease proficient counterparts. The data indicates that loss of proofreading action increases the frequency of UV-induced frameshifts.^[7]

Detection [edit]

Fluorescence [edit]

The effects of neighboring bases and secondary construction to discover the frequency of frameshift mutations has been investigated in depth using fluorescence. Fluorescently tagged DNA, by means of base analogues, permits one to study the local changes of a Dna sequence.^[eight] Studies on the furnishings of the length of the primer strand reveal that an equilibrium mixture of four hybridization conformations was observed when template bases looped-out every bit a bulge, i.e. a structure flanked on both sides past duplex DNA. In contrast, a double-loop structure with an unusual unstacked DNA conformation at its downstream edge was observed when the extruded bases were positioned at the primer–template junction, showing that misalignments can be modified by neighboring DNA secondary structure.^[9]

Sequencing [edit]

A deletion mutation alters every codon post-obit information technology, and can make poly peptide synthesis end prematurely by forming a stop codon.

Sanger sequencing and pyrosequencing are two methods that have been used to find frameshift mutations, however, it is likely that data generated will non exist of the highest quality. Even still, 1.96 million indels have been identified through Sanger sequencing that do not overlap with other databases. When a frameshift mutation is observed it is compared against the Human being Genome Mutation Database (HGMD) to determine if the mutation has a damaging upshot. This is washed past looking at 4 features. First, the ratio between the affected and conserved Deoxyribonucleic acid, second the location of the mutation relative to the transcript, 3rd the ratio of conserved and affected amino acids and finally the distance of the indel to the end of the exon.^[ten]

Massively Parallel Sequencing is a newer method that can exist used to notice mutations. Using this method, upward to 17 gigabases tin be sequenced at in one case, as opposed to limited ranges for Sanger sequencing of only about 1 kilobase. Several technologies are available to perform this test and information technology is being looked at to exist used in clinical applications.^[11] When testing for unlike carcinomas, current methods just permit for looking at i cistron at a fourth dimension. Massively Parallel Sequencing tin exam for a variety of cancer causing mutations at one time every bit opposed to several specific tests.^[12] An experiment to decide the accuracy of this newer sequencing method tested for 21 genes and had no faux positive calls for frameshift mutations.^[xiii]

Diagnosis [edit]

A Us patent (5,958,684) in 1999 by Leeuwen, details the methods and reagents for diagnosis of diseases caused past or associated with a gene having a somatic mutation giving ascent to a frameshift mutation. The methods include providing a tissue or fluid sample and conducting gene analysis for frameshift mutation or a protein from this blazon of mutation. The nucleotide sequence of the suspected cistron is provided from published gene sequences or from cloning and sequencing of the suspect factor. The amino acid sequence encoded by the gene is and then predicted.^[14]

Frequency [edit]

Despite the rules that govern the genetic code and the various mechanisms present in a cell to ensure the correct transfer of genetic information during the procedure of Dna replication too as during translation, mutations do occur; frameshift mutation is not the only type. There are at least ii other types of recognized point mutations, specifically missense mutation and nonsense mutation.^[ane] A frameshift mutation can drastically change the coding capacity (genetic information) of the bulletin.^[1] Small insertions or deletions (those less than xx base pairs) make up 24% of mutations that manifest in currently recognized genetic disease.^[10]

Frameshift mutations are establish to exist more mutual in repeat regions of DNA. A reason for this is because of slipping of the polymerase enzyme in repeat regions, allowing for mutations to enter the sequence.^[fifteen] Experiments can be run to determine the frequency of the frameshift mutation by adding or removing a pre-set number of nucleotides. Experiments have been run past adding four basepairs, called the +4 experiments, merely a squad from Emory University looked at the difference in frequency of the mutation by both adding and deleting a base pair. It was shown that there was no difference in the frequency between the addition and deletion of a base of operations pair. There is nevertheless, a departure in the end result of the protein.^[xv]

Huntington's disease is one of the 9 codon reiteration disorders caused by polyglutamine expansion mutations that include spino-cerebellar ataxia (SCA) one, 2, six, 7 and 3, spinobulbar muscular cloudburst and dentatorubal-pallidoluysianatrophy. At that place may exist a link between diseases caused past polyglutamine and polyalanine expansion mutations, as frame shifting of the original SCA3 cistron production encoding CAG/polyglutamines to GCA/polyalanines. Ribosomal slippage during translation of the SCA3 protein has been proposed as the mechanism resulting in shifting from the polyglutamine to the polyalanine-encoding frame. A dinucleotide deletion or single nucleotide insertion within the polyglutamine tract of huntingtin exon i would shift the CAG, polyglutamineen coding frame by +ane (+i frame shift) to the GCA, polyalanine-encoding frame and introduce a novel epitope to the C terminus of Htt exon 1 (APAAAPAATRPGCG).^[xvi]

Diseases [edit]

Several diseases have frameshift mutations as at least part of the crusade. Knowing prevalent mutations tin can besides assistance in the diagnosis of the illness. Currently at that place are attempts to use frameshift mutations beneficially in the handling of diseases, irresolute the reading frame of the amino acids.

Frequency of mutations on BRCA1 gene on chromosome 17

Frequency of mutations on BRCA2 gene on chromosome 13

Cancer [edit]

Frameshift mutations are known to be a factor in colorectal cancer likewise as other cancers with microsatellite instability. As stated previously, frameshift mutations are more probable to occur in a region of repeat sequence. When Deoxyribonucleic acid mismatch repair does non fix the addition or deletion of bases, these mutations are more than likely to be pathogenic. This may exist in part because the tumor is non told to finish growing. Experiments in yeast and bacteria aid to testify characteristics of microsatellites that may contribute to defective Dna mismatch repair. These include the length of the microsatellite, the makeup of the genetic textile and how pure the repeats are. Based on experimental results longer microsatellites have a higher rate of frameshift mutations. The flanking DNA can also contribute to frameshift mutations.^[17] In prostate cancer a frameshift mutation changes the open up reading frame (ORF) and prevents apoptosis from occurring. This leads to an unregulated growth of the tumor. While in that location are environmental factors that contribute to the progression of prostate cancer, there is also a genetic component. During testing of coding regions to identify mutations, 116 genetic variants were discovered, including 61 frameshift mutations.^[18] In that location are over 500 mutations on chromosome 17 that seem to play a function in the development of breast and ovarian cancer in the BRCA1 gene, many of which are frameshift.^[19]

Crohn's illness [edit]

Crohn'due south illness has an association with the NOD2 gene. The mutation is an insertion of a Cytosine at position 3020. This leads to a premature stop codon, shortening the protein that is supposed to be transcribed. When the protein is able to class normally, information technology responds to bacterial liposaccharides, where the 3020insC mutation prevents the protein from existence responsive.^[xx]

Cystic fibrosis [edit]

Cystic fibrosis (CF) is a affliction based on mutations in the CF transmembrane conductance regulator (CFTR) gene. There are over 1500 mutations identified, but not all cause the disease.^[21] Almost cases of cystic fibrosis are a result of the ∆F508 mutation, which deletes the unabridged amino acid. Two frameshift mutations are of interest in diagnosing CF, CF1213delT and CF1154-insTC. Both of these mutations usually occur in tandem with at least one other mutation. They both lead to a small decrease in the function of the lungs and occur in about 1% of patients tested. These mutations were identified through Sanger sequencing.^[22]

HIV [edit]

CCR5 is one of the prison cell entry co-factors associated with HIV, about frequently involved with nonsyncytium-inducing strains, is most apparent in HIV patients as opposed to AIDS patients. A 32 base pair deletion in CCR5 has been identified as a mutation that negates the likelihood of an HIV infection. This region on the open up reading frame ORF contains a frameshift mutation leading to a premature cease codon. This leads to the loss of the HIV-coreceptor office in vitro. CCR5-1 is considered the wild type and CCR5-2 is considered to be the mutant allele. Those with a heterozygous mutation for the CCR5 were less susceptible to the evolution of HIV. In a study, despite high exposure to the HIV virus, at that place was no one homozygous for the CCR5 mutation that tested positive for HIV.^[iii]

Tay–Sachs disease [edit]

Tay–Sachs affliction is a fatal disease affecting the fundamental nervous system. It is most frequently constitute in infants and minor children. Disease progression begins in the womb but symptoms do non announced until approximately half-dozen months of age. There is no cure for the disease.^[23] Mutations in the β-hexosaminidase A (Hex A) cistron are known to affect the onset of Tay-Sachs, with 78 mutations of different types being described, 67 of which are known to crusade disease. About of the mutations observed (65/78) are unmarried base of operations substitutions or SNPs, 11 deletions, one large and 10 small, and 2 insertions. viii of the observed mutations are frameshift, half-dozen deletions and 2 insertions. A 4 base pair insertion in exon xi is observed in 80% of Tay-Sachs affliction presence in the Ashkenazi Jewish population. The frameshift mutations lead to an early cease codon which is known to play a role in the disease in infants. Delayed onset disease appears to exist caused by 4 different mutations, one being a iii base pair deletion.^[24]

Smith–Magenis syndrome [edit]

Smith–Magenis syndrome (SMS) is a complex syndrome involving intellectual disabilities, slumber disturbance, behavioural problems, and a variety of craniofacial, skeletal, and visceral anomalies. The bulk of SMS cases harbor an ~three.5 Mb common deletion that encompasses the retinoic acid induced-1 (RAI1) gene. Other cases illustrate variability in the SMS phenotype not previously shown for RAI1 mutation, including hearing loss, absenteeism of self-abusive behaviours, and mild global delays. Sequencing of RAI1 revealed mutation of a heptamericC-tract (CCCCCCC) in exon 3 resulting in frameshift mutations. Of the 7 reported frameshift mutations occurring in poly C-tracts in RAI1, 4 cases (~57%) occur at this heptameric C-tract. The results betoken that this heptameric C-tract is a preferential recombination hotspot insertion/deletions (SNindels) and therefore a primary target for assay in patients suspected for mutations in RAI1.^[25]

Hypertrophic cardiomyopathy [edit]

Hypertrophic cardiomyopathy is the most common cause of sudden death in young people, including trained athletes, and is caused past mutations in genes encoding proteins of the cardiac sarcomere. Mutations in the Troponin C factor (TNNC1) are a rare genetic cause of hypertrophic cardiomyopathy. A recent study has indicated that a frameshift mutation (c.363dupG or p.Gln122AlafsX30) in Troponin C was the crusade of hypertrophic cardiomyopathy (and sudden cardiac death) in a nineteen-year-old male.^[26]

Cures [edit]

Finding a cure for the diseases caused by frameshift mutations is rare. Enquiry into this is ongoing. Ane example is a master immunodeficiency (PID), an inherited status which tin can lead to an increase in infections. There are 120 genes and 150 mutations that play a function in primary immunodeficiencies. The standard handling is currently cistron therapy, simply this is a highly risky treatment and can often atomic number 82 to other diseases, such equally leukemia. Cistron therapy procedures include modifying the zinc fringer nuclease fusion poly peptide, cleaving both ends of the mutation, which in turn removes it from the sequence. Antisense-oligonucleotide mediated exon skipping is another possibility for Duchenne muscular dystrophy. This process allows for passing over the mutation so that the rest of the sequence remains in frame and the function of the poly peptide stays intact. This, however, does not cure the disease, just treats symptoms, and is simply practical in structural proteins or other repetitive genes. A 3rd form of repair is revertant mosaicism, which is naturally occurring by creating a opposite mutation or a mutation at a second site that corrects the reading frame. This reversion may happen past intragenic recombination, mitotic gene conversion, 2d site Dna slipping or site-specific reversion. This is possible in several diseases, such every bit X-linked severe combined immunodeficiency (SCID), Wiskott–Aldrich syndrome, and Bloom syndrome. In that location are no drugs or other pharmacogenomic methods that help with PIDs.^[27]

A European patent (EP1369126A1) in 2003 by Bork records a method used for prevention of cancers and for the curative treatment of cancers and precancers such as DNA-mismatch repair deficient (MMR) sporadic tumours and HNPCC associated tumours. The idea is to use immunotherapy with combinatorial mixtures of neoplasm-specific frameshift mutation-derived peptides to arm-twist a cytotoxic T-prison cell response specifically directed against tumour cells.^[28]

References [edit]

^ ^a ^b ^c ^d ^e ^f ^g ^h ⁱ ^j Losick, Richard; Watson, James D.; Baker, Tania A.; Bell, Stephen; Gann, Alexander; Levine, Michael W. (2008). Molecular biological science of the factor (6th ed.). San Francisco: Pearson/Benjamin Cummings. ISBN978-0-8053-9592-one.
^ "DNA Is Constantly Changing through the Process of Mutation". Nature . Retrieved 17 May 2019.
^ ^a ^b Zimmerman PA, Buckler-White A, Alkhatib G, Spalding T, Kubofcik J, Combadiere C, Weissman D, Cohen O, Rubbert A, Lam G, Vaccarezza 1000, Kennedy PE, Kumaraswami 5, Giorgi JV, Detels R, Hunter J, Chopek Grand, Berger EA, Fauci AS, Nutman TB, Tater PM (January 1997). "Inherited resistance to HIV-ane conferred past an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk". Molecular Medicine (Cambridge, Mass.). 3 (1): 23–36. PMC2230106. PMID 9132277.
^ Negoro S, Ohki T, Shibata Northward, Mizuno N, Wakitani Y, Tsurukame J, Matsumoto Yard, Kawamoto I, Takeo Chiliad, Higuchi Y (November 2005). "X-ray crystallographic analysis of six-aminohexanoate-dimer hydrolase: molecular basis for the birth of a nylon oligomer-degrading enzyme". J Biol Chem. 280 (47): 39644–52. doi:10.1074/jbc.m505946200. PMID 16162506.
^ Zhang, J (August 2004). "Host RNA polymerase Two makes minimal contributions to retroviral frame-shift mutations". The Journal of General Virology. 85 (Pt 8): 2389–95. doi:10.1099/vir.0.80081-0. PMID 15269381.
^ Cox, Michael; Nelson, David R.; Lehninger, Albert L (2008). Lehninger principles of biochemistry . San Francisco: W.H. Freeman. ISBN978-0-7167-7108-1.
^ Sagher, Daphna; Turkington, Edith; Acharya, Sonia; Strauss, Bernard (July 1994). "Product of UV-induced Frameshift Mutations in Vitro by DNA Polymerases Deficient in 3′ → 5′ Exonuclease Action". Journal of Molecular Biology. 240 (3): 226–242. doi:10.1006/jmbi.1994.1437. PMID 8028006.
^ Johnson, Neil P.; Walter A. Baase; Peter H. von Hippel (March 2004). "Low-energy round dichroism of two-aminopurine dinucleotide as a probe of local conformation of DNA and RNA". Proc Natl Acad Sci U S A. 101 (10): 3426–31. Bibcode:2004PNAS..101.3426J. doi:x.1073/pnas.0400591101. PMC373478. PMID 14993592.
^ Baase, Walter A.; Davis Jose; Benjamin C. Ponedel; Peter H. von Hippel; Neil P. Johnson (2009). "Deoxyribonucleic acid models of trinucleotide frameshift deletions: the formation of loops and bulges at the primer–template junction". Nucleic Acids Research. 37 (v): 1682–9. doi:10.1093/nar/gkn1042. PMC2655659. PMID 19155277.
^ ^a ^b Hu, J; Ng, PC (9 February 2012). "Predicting the effects of frameshifting indels". Genome Biology. thirteen (2): R9. doi:x.1186/gb-2012-13-2-r9. PMC3334572. PMID 22322200.
^ Tucker, Tracy; Marra, Marco; Friedman, Jan G. (2009). "Massively Parallel Sequencing: The Next Big Matter in Genetic Medicine". The American Journal of Human Genetics. 85 (2): 142–154. doi:10.1016/j.ajhg.2009.06.022. PMC2725244. PMID 19679224.
^ Walsh, T.; Casadei, Due south.; Lee, Thousand. M.; Pennil, C. C.; Nord, A. S.; Thornton, A. Thousand.; Roeb, W.; Agnew, Yard. J.; Stray, S. M.; Wickramanayake, A.; Norquist, B.; Pennington, K. P.; Garcia, R. L.; King, M.-C.; Swisher, E. Chiliad. (2011). "From the Encompass: Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing". Proc Natl Acad Sci U S A. 108 (44): 18032–vii. Bibcode:2011PNAS..10818032W. doi:10.1073/pnas.1115052108. PMC3207658. PMID 22006311.
^ Walsh, T.; Lee, Thou. K.; Casadei, S.; Thornton, A. M.; Stray, S. Thou.; Pennil, C.; Nord, A. Southward.; Mandell, J. B.; Swisher, E. M.; King, Thousand.-C. (2010). "Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing". Proc Natl Acad Sci U Due south A. 107 (28): 12629–33. Bibcode:2010PNAS..10712629W. doi:10.1073/pnas.1007983107. PMC2906584. PMID 20616022.
^ US Patent 5,958,684 (September 28, 1999) "Diagnosis of Neurodegenerative Disease" by Leeuwen et al
^ ^a ^b Harfe, BD; Jinks-Robertson, S (July 1999). "Removal of frameshift intermediates by mismatch repair proteins in Saccharomyces cerevisiae". Molecular and Cellular Biology. xix (7): 4766–73. doi:10.1128/MCB.19.seven.4766. PMC84275. PMID 10373526.
^ Davies, J Eastward; Rubinsztein, D C (2006). "Polyalanine and polyserine frameshift products in Huntington's disease". Journal of Medical Genetics. 43 (11): 893–896. doi:10.1136/jmg.2006.044222. PMC2563184. PMID 16801344.
^ Schmoldt, A; Benthe, HF; Haberland, G (i September 1975). "Digitoxin metabolism by rat liver microsomes". Biochemical Pharmacology. 24 (17): 1639–41. doi:10.1016/0006-2952(75)90094-v. PMID 10.
^ Xu, XiaoLin; Zhu, KaiChang; Liu, Feng; Wang, Yue; Shen, JianGuo; Jin, Jizhong; Wang, Zhong; Chen, Lin; Li, Jiadong; Xu, Min (May 2013). "Identification of somatic mutations in human prostate cancer by RNA-Seq". Factor. 519 (2): 343–vii. doi:ten.1016/j.gene.2013.01.046. PMID 23434521.
^ "Cancer Genomics". National Cancer Institute at the National Constitute of Wellness. Archived from the original on xviii March 2013. Retrieved 24 March 2013.
^ Ogura Y, Bonen DK, Inohara Due north, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuñez G, Cho JH (May 31, 2001). "A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease" (PDF). Nature. 411 (6837): 603–six. Bibcode:2001Natur.411..603O. doi:ten.1038/35079114. hdl:2027.42/62856. PMID 11385577. S2CID 205017657.
^ Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Stone MJ, Campbell Pw (2008). "Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Written report". The Journal of Pediatrics. 153 (ii): S4–S14. doi:10.1016/j.jpeds.2008.05.005. PMC2810958. PMID 18639722.
^ Iannuzzi, MC; Stern, RC; Collins, FS; Hon, CT; Hidaka, North; Potent, T; Becker, Fifty; Drumm, ML; White, MB; Gerrard, B (February 1991). "2 frameshift mutations in the cystic fibrosis cistron". American Journal of Human being Genetics. 48 (2): 227–31. PMC1683026. PMID 1990834.
^ "Learning Almost Tay-Sachs Illness". National Human Genome Research Plant. Retrieved 24 March 2013.
^ Myerowitz, R (1997). "Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene". Homo Mutation. 9 (3): 195–208. doi:ten.1002/(SICI)1098-1004(1997)9:iii<195::Help-HUMU1>3.0.CO;2-seven. PMID 9090523.
^ Truong, Hoa T; Dudding, Tracy; Blanchard, Christopher L.; Elsea, Sarah H (2010). "Frameshift mutation hotspot identified in Smith-Magenis syndrome: instance report and review of literature". BMC Medical Genetics. 11 (1): 142. doi:10.1186/1471-2350-eleven-142. PMC2964533. PMID 20932317.
^ Chung WK, Kitner C, Maron BJ (June 2011). "Novel frameshift mutation in Troponin C ( TNNC1) associated with hypertrophic cardiomyopathy and sudden decease". Cardiol Immature. 21 (3): 345–eight. doi:ten.1017/S1047951110001927. PMID 21262074. S2CID 46682245.
^ Hu, Hailiang; Gatti, Richard A (2008). "New approaches to treatment of master immunodeficiencies: fixing mutations with chemicals". Current Opinion in Allergy and Clinical Immunology. 8 (6): 540–6. doi:10.1097/ACI.0b013e328314b63b. PMC2686128. PMID 18978469.
^ European Patent [ane] (December 10, 2003) "Employ of coding microsatellite region frameshift mutation-derived peptides for treating cancer" by Bork et al

External links [edit]

Frameshift+Mutation at the U.s. National Library of Medicine Medical Discipline Headings (MeSH)
NCBI dbSNP database — "a central repository for both single base nucleotide substitutions and short deletion and insertion polymorphisms"
Wise2 - aligns a protein against a Dna sequence assuasive frameshifts and introns
FastY - compare a Deoxyribonucleic acid sequence to a protein sequence database, allowing gaps and frameshifts
Path - tool that compares two frameshift proteins (back-translation principle)
HGMD - Human Genome Mutation Database

Source: https://en.wikipedia.org/wiki/Frameshift_mutation

Posted by: haleysoccut.blogspot.com